PacBio Files Additional Proxy Materials

Ticker: PACB · Form: DEFA14A · Filed: 2024-05-30T00:00:00.000Z

Sentiment: neutral

Topics: sec-filing, proxy-statement, shareholder-materials

TL;DR

PacBio dropped more shareholder info, no fee paid.

AI Summary

Pacific Biosciences of California, Inc. (PacBio) filed a Definitive Additional Materials (DEFA14A) on May 30, 2024. This filing relates to the company's proxy statement and does not involve a fee, as indicated by the 'No fee required' checkbox. The document is a standard filing for public companies to provide additional materials to shareholders.

Why It Matters

This filing indicates that Pacific Biosciences is providing supplementary information to its shareholders, likely related to upcoming corporate actions or annual meetings, which is crucial for shareholder engagement and voting.

Risk Assessment

Risk Level: low — This is a routine SEC filing for additional proxy materials and does not inherently present new risks.

Key Players & Entities

FAQ

What type of SEC filing is this?

This is a DEFA14A, which signifies Definitive Additional Materials filed with the SEC.

Who is the filing company?

The filing company is Pacific Biosciences of California, Inc.

When was this filing made?

The filing was made on May 30, 2024.

Is there a fee associated with this filing?

No, the filing explicitly states 'No fee required'.

What is the purpose of a DEFA14A filing?

A DEFA14A filing is used to provide additional materials to shareholders related to a proxy statement, often after the initial preliminary filing.

From the Filing

0001299130-24-000127.txt : 20240530 0001299130-24-000127.hdr.sgml : 20240530 20240529215204 ACCESSION NUMBER: 0001299130-24-000127 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 16 FILED AS OF DATE: 20240530 DATE AS OF CHANGE: 20240529 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CENTRAL INDEX KEY: 0001299130 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 161590339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34899 FILM NUMBER: 241000560 BUSINESS ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-521-8000 MAIL ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC DATE OF NAME CHANGE: 20050829 FORMER COMPANY: FORMER CONFORMED NAME: NANOFLUIDICS INC DATE OF NAME CHANGE: 20040729 DEFA14A 1 a2024defa14a-additionalmat.htm DEFA14A Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☒ Definitive Additional Materials ☐ Soliciting Material Pursuant to §240.14a-12 Pacific Biosciences of California, Inc. (Name of Registrant as Specified In Its Charter) Payment of Filing Fee (Check the appropriate box): ☒ No fee required ☐ Fee paid previously with preliminary materials ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 GRAPHIC 2 a2024_annualxshareholderxmn.jpg begin 644 a2024_annualxshareholderxmn.jpg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

View on Read The Filing